Latest Breaking News On - Glucagon like peptide - Page 3 : comparemela.com

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2023 Earnings Call Transcript

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2023 Earnings Call Transcript October 25, 2023 Viking Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.23 EPS, expectations were $-0.22. Operator: Welcome to the Viking Therapeutics Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we […]

Greg-zante
Exchange-commission
Obesity-society
Brian-lian
Chief-financial
Glucagon-like-peptide
Glucose-dependent-insulinotropic-polypeptide
Productive-states
Rich-people-own-real
Viking-therapeutics
Nc

Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2023 Earnings Call Transcript

Operator: Welcome to the Viking Therapeutics Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.

Steve-seedhouse
Raymond-james
Joon-lee
Stephanie-diaz
Greg-zante
Jay-olson
Steven-seedhouse
Exchange-commission
Therapeutics-inc
Obesity-society
Nasdaq
Viking-therapeutics

Personal View: Plan sponsors should wait on weight-loss drugs | Crain's Cleveland Business

Personal View: Plan sponsors should wait on weight-loss drugs | Crain's Cleveland Business
crainscleveland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crainscleveland.com Daily Mail and Mail on Sunday newspapers.

Nelly-rose
Rx-solutions
Drug-administration
Glucagon-like-peptide

Study reveals surge in use of weight loss-linked drugs in California health system

Study reveals surge in use of weight loss-linked drugs in California health system
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Irvine
California
United-states
American
Jonathanh-watanabe
Jonathan-watanabe
Journal-of-the-american-pharmacists-association
University-of-california-health-data-warehouse
University-of-california
American-pharmacists-association
California-health-data-warehouse
Glucagon-like-peptide

Skyrocketing demand for weight-loss drugs prompts calls for informed prescribing

The study reveals a significant increase in the usage of GLP-1 receptor agonists, particularly Ozempic and Trulicity, for weight management and Type 2 diabetes in the U.S. from 2014 to 2022. Amidst rapid growth and shortages, the paper calls for evidence-based decision-making to ensure stable medication supply and effective treatment.

United-states
American
Natalia-varlei
Drug-administration
Journal-of-the-american-pharmacists-association
American-pharmacists-association
Hispanic-black
Glucagon-like-peptide
Agonist-use
Drugs
Agonist
Wood